1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the High Grade Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on High Grade Non-Hodgkin Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating High Grade Non-Hodgkin Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
High Grade Non-Hodgkin Lymphoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of High Grade Non-Hodgkin Lymphoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of High Grade Non-Hodgkin Lymphoma 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Incyte Corporation 24
Clinical Trial Overview of Incyte Corporation 24
Amgen Inc. 25
Clinical Trial Overview of Amgen Inc. 25
Clinical Trial Overview of Top Institutes / Government 26
Memorial Sloan Kettering Cancer Center 26
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 26
National Cancer Institute 27
Clinical Trial Overview of National Cancer Institute 27
The Children's Hospital at Westmead 28
Clinical Trial Overview of The Children's Hospital at Westmead 28
Mater Medical Research Institute 29
Clinical Trial Overview of Mater Medical Research Institute 29
Lymphoma Trials Office 30
Clinical Trial Overview of Lymphoma Trials Office 30
Cancer Treatment Centers of America 31
Clinical Trial Overview of Cancer Treatment Centers of America 31
Ottawa Regional Cancer Foundation 32
Clinical Trial Overview of Ottawa Regional Cancer Foundation 32
Case Comprehensive Cancer Center 33
Clinical Trial Overview of Case Comprehensive Cancer Center 33
Albert Einstein College of Medicine of Yeshiva University 34
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 34
Johann Wolfgang Goethe University Hospitals 35
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 35
Five Key Clinical Profiles 36
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 66

List of Tables
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of High Grade Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 19
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2014* 19
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
High Grade Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2014* 24
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 25
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 26
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 27
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital at Westmead, 2014* 28
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mater Medical Research Institute, 2014* 29
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Lymphoma Trials Office, 2014* 30
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Treatment Centers of America, 2014* 31
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Regional Cancer Foundation, 2014* 32
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 33
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2014* 34
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 35

List of Figures
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of High Grade Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
High Grade Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
GlobalData Methodology 64

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.